Sangamo Follow-Up: Giro-Vec And STAC-BBB? Check.

Experience: Former Fund Manager of a Hedge Fund focused on Biotech and Pharmaceutical companies. Over 20 years in the BioPharma Industry, including various roles on the commercial side. Investing Goal: Outperform the XBI each year by identifying and then investing in assets that should change the current standard of care in a particular disease. Portfolio sizing: Typically, high risk/high reward plays will be acquired up to 2 percent positions in my portfolio. More moderate risk/moderate reward positions ma ...